| Product NDC: | 52670-552 |
| Proprietary Name: | Ammonia N 13 |
| Non Proprietary Name: | ammonia n-13 |
| Active Ingredient(s): | 37.5 mCi/mL & nbsp; ammonia n-13 |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52670-552 |
| Labeler Name: | Mayo Clinic |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA203321 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130225 |
| Package NDC: | 52670-552-30 |
| Package Description: | 30 mL in 1 VIAL, SINGLE-DOSE (52670-552-30) |
| NDC Code | 52670-552-30 |
| Proprietary Name | Ammonia N 13 |
| Package Description | 30 mL in 1 VIAL, SINGLE-DOSE (52670-552-30) |
| Product NDC | 52670-552 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ammonia n-13 |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20130225 |
| Marketing Category Name | ANDA |
| Labeler Name | Mayo Clinic |
| Substance Name | AMMONIA N-13 |
| Strength Number | 37.5 |
| Strength Unit | mCi/mL |
| Pharmaceutical Classes | Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] |